M R Jaff
Affiliation: Massachusetts General Hospital
- Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trialMichael R Jaff
Massachusetts General Hospital, Boston, MA Electronic address
Am Heart J 169:479-85. 2015..The pivotal LEVANT 2 trial was designed in collaboration with the US Food and Drug Administration to demonstrate safety and efficacy in a large population and to obtain US Food and Drug Administration approval...
- Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trialMichael R Jaff
The Vascular Center, Massachusetts General Hospital, Boston, Massachusetts, USA
Catheter Cardiovasc Interv 80:343-50. 2012..The HERCULES Trial is a prospective, multicenter trial of renal stenting in patients with uncontrolled HTN and ARAS evaluating the safety and effectiveness of the RX Herculink Elite Renal Stent System (Abbott Vascular, Santa Clara, CA)...
- The Massachusetts General Hospital Vascular Center: emergence of a multidisciplinary program designed to improve quality outcomes for patientsMichael R Jaff
Massachusetts General Hospital, Boston, MA 02114, USA
Hosp Pract (1995) 37:22-32. 2009....
- Advances in the management of patients with vascular diseaseMichael R Jaff
Massachusetts General Hospital Vascular Center, 55 Fruit Street, Boston, MA 02114, USA
Expert Rev Cardiovasc Ther 10:151-3. 2012..This year, VIVA attracted some of the most important studies presented by international investigators. In this article details regarding new stent technologies in the aorta, peripheral artery and carotid arteries will be highlighted...
- Turf wars: what certification brings to the public and the physicianMichael R Jaff
Division of Cardiovascular Medicine, Massachusetts General Hospital, 32 Fruit Street, Boston, MA 02114, USA
Am Heart Hosp J 3:277-8. 2005
- The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP studyM R Jaff
VasCore, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Catheter Cardiovasc Interv 68:684-9. 2006..This is the report of the duplex ultrasound (DUS) substudy of the CLIP trial...
- High utilization rate of vena cava filters in deep vein thrombosisMichael R Jaff
Massachusetts General Hospital, 55 Fruit Street, Yawkey Center for Outpatient Care, Room 5938, Boston, Massachusetts 02114, USA
Thromb Haemost 93:1117-9. 2005..Many of these patients may have warranted less invasive methods of venous thromboembolism prophylaxis. Improved physician education regarding mechanical and pharmacologic prophylaxis alternatives might reduce the use of IVCFs...
- Two-year clinical evaluation of the Zilver vascular stent for symptomatic iliac artery diseaseMichael R Jaff
Massachusetts General Hospital Vascular Center, 55 Fruit Street, GB 800, Boston, MA 02114, USA
J Vasc Interv Radiol 21:1489-94. 2010....
- Imaging of the carotid arteries: the role of duplex ultrasonography, magnetic resonance arteriography, and computerized tomographic arteriographyMichael R Jaff
Section of Vascular Medicine, Division of Cardiovascular Medicine and the Division of Vascular Endovascular Surgery, The Massachusetts General Hospital Vascular Center, Boston 02114, USA
Vasc Med 13:281-92. 2008..Physical examination is inaccurate in determining the presence and severity of carotid artery disease. Therefore, reliable imaging tests which offer little risk to the patient are required...
- Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?Michael R Jaff
Harvard Medical School, Massachusetts General Hospital Vascular Center, 55 Fruit Street, Boston, MA 02114, USA
Catheter Cardiovasc Interv 74:S17-21. 2009....
- Imaging the carotid bifurcation: toward standardizationMichael R Jaff
Harvard Medical School and Vascular Center, Massachusetts General Hospital, Boston, MA 02114, USA
Semin Vasc Surg 21:73-9. 2008..This article will highlight the current strategies for carotid bifurcation imaging and will provide a diagnostic algorithm useful for centers involved in the management of carotid artery disease...
- Unusual causes of intermittent claudication: popliteal artery entrapment syndrome, cystic adventitial disease, fibromuscular dysplasia, and endofibrosisEthan C Korngold
Michael R Jaff, DO Section of Vascular Medicine, Division of Cardiovascular Medicine, Massachusetts General Hospital, 55 Fruit Street, Gray Bigelow 832, Boston, MA 02114, USA
Curr Treat Options Cardiovasc Med 11:156-66. 2009....
- Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDMichael R Jaff
Vascular Center, Massachusetts General Hospital, Boston, MA 02114, USA
Circulation 119:452-8. 2009..The objective of this phase-III trial was to assess the effect of a potent anti-Chlamydial agent, rifalazil, on peak walking time in patients with symptomatic peripheral artery disease...
- Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial diseaseMichael R Jaff
Massachusetts General Hospital Vascular Center, Boston, MA 02114, USA
Ann Vasc Surg 24:577-87. 2010..Despite the explosive advances in endovascular therapy, cost-effective methods of care have not been well defined. We analyze therapeutic strategies, outcomes, and medical cost of treatment among Medicare patients with PAD...
- Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat"Thomas J Kiernan
Section of Vascular Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA
Tech Vasc Interv Radiol 13:2-10. 2010..This article reviews the comprehensive diagnostic algorithm and medical treatment strategies for patients with infrainguinal PAD...
- "The challenge facing renal artery revascularization: what have we not proven and why we must"?B G Hynes
Section of Vascular Medicine, Division of Cardiology, Massachusetts General Hospital, Boston MA, USA
Acta Chir Belg 110:575-83. 2010..We must attempt to determine which patients are likely to benefit from renal artery stenting, assess the nuances of the percutaneous procedure and review the current literature pertaining to renal artery stenting...
- May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical associationThomas J Kiernan
Department of Interventional Cardiology and Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
Stroke 40:1502-4. 2009..We aimed to investigate the incidence of May-Thurner syndrome in patients with cryptogenic stroke with patent foramen ovale...
- Renal artery revascularization: collaborative approaches for specialistsThomas J Kiernan
Department of Vascular Medicine and Intervention, Massachusetts General Hospital, Boston, MA 02114, USA
Adv Chronic Kidney Dis 15:363-9. 2008..Renal revascularization with a distal embolic protection device is a promising strategy in reducing the risk of atheroembolism and deterioration in kidney function...
- Correlates of carotid stenosis in patients undergoing coronary artery bypass grafting--a case control studyThomas J Kiernan
Department of Medicine, Division of Cardiology, Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
Vasc Med 14:233-7. 2009..Unlike previous studies, LMCA or extent of CAD did not correlate with significant carotid artery disease. Using these predictive models, a prospective outcomes trial is required to validate these criteria...
- The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?Joshua A Beckman
Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass, USA
Circulation 114:861-6. 2006..We encourage the USPSTF to reevaluate the extant data, add vascular specialty expertise to its review group, and reconsider its recommendation...
- Treatment strategies for peripheral artery diseaseAndrew B McCann
Vascular Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Expert Opin Pharmacother 10:1571-86. 2009..Endovascular techniques are commonly used in these patients. Combined pharmacological and endovascular strategies will play an increasing role in management of these patients in the future...
- Medical management of venous thromboembolic diseaseSteven Deitelzweig
Ochsner Clinic Foundation, New Orleans, Louisiana, Section of Vascular Medicine, Lenox Hill Hospital, New York, NY, USA
Tech Vasc Interv Radiol 7:63-7. 2004..Emerging oral direct thrombin inhibitors and other novel agents stand to move the treatment of patients with venous thromboemboli to even greater levels of safety and efficacy...
- Carotid duplex ultrasound velocity measurements versus intravascular ultrasound in detecting carotid in-stent restenosisBryan P Yan
Section of Vascular Medicine, Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Mass 02114, USA
Circ Cardiovasc Interv 2:438-43. 2009..Duplex ultrasonography criteria for assessing the severity of carotid artery (CA) in-stent restenosis are not well established...
- Treatment of renal artery in-stent restenosis with sirolimus-eluting stentsThomas J Kiernan
Department of Interventional Cardiology and Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
Vasc Med 15:3-7. 2010..05). In conclusion, placement of a SES for the treatment of ISR in renal arteries is associated with high initial technical success but significant restenosis on duplex ultrasonography at follow-up...
- External iliac artery endofibrosis in an amateur runner: hemodynamic, angiographic, histopathological evaluation and percutaneous revascularizationAndrew O Maree
Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Vasc Med 12:203-6. 2007..The diagnosis was made by a combination of hemodynamic, angiographic and histopathological assessment and percutaneous revascularization was performed using a balloon expandable stent...
- Optimal risk factor modification and medical management of the patient with peripheral arterial diseaseYung Wei Chi
Department of Cardiology, Section of Vascular Medicine, Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
Catheter Cardiovasc Interv 71:475-89. 2008..This article reviews the current medical treatment and risk factor modification of patients with PAD...
- Postgraduate training in vascular medicine: proposed requirements and standardsMark A Creager
Harvard Medical School, Boston, MA, USA
Vasc Med 8:47-52. 2003
- Should all coronary angiographies be accompanied by a renal arteriogram (and stent)? The argument forMichael R Jaff
Vascular Medicine, Massachusetts General Hospital, Boston, MA, USA
J Clin Hypertens (Greenwich) 6:513-5. 2004
- An 82-year-old woman with worsening hypertension: review of renal artery stenosisKenneth Rosenfield
Harvard Medical School, and Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, USA
JAMA 300:2036-44. 2008..The role of medical therapy, surgery, and endovascular therapy are reviewed, particularly in the context of guidelines and systematic reviews to help clinicians and patients facing this challenging decision...
- Pharmacotherapy for peripheral arterial disease: emerging therapeutic optionsMichael R Jaff
The Vascular Ultrasound Core Laboratory, Morristown NJ 07960, USA
Angiology 53:627-33. 2002..Revascularization procedures, including nonsurgical and surgical techniques, can thus be reserved to improve patency and reduce the risk of limb loss in patients with PAD and IC with more severe impairment...
- Atherosclerotic Vascular Disease Conference: Writing Group IV: imagingJeffrey W Olin
Circulation 109:2626-33. 2004
- Lower extremity arterial disease. Diagnostic aspectsMichael R Jaff
Vascular Ultrasound Core Laboratory, Morristown, NJ, USA
Cardiol Clin 20:491-500, v. 2002....
- The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial resultsDonald Ponec
Department of Radiology, Tri City Medical Center, 4002 Vista Way, Oceanside, CA 92056, USA
J Vasc Interv Radiol 15:911-8. 2004....
- Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial diseaseKrishna J Rocha-Singh
Prairie Vascular Institute, Springfield, Illinois 62794 9420, USA
Catheter Cardiovasc Interv 69:910-9. 2007..This analysis proposes safety and performance goals for prospective single-arm trials of bare nitinol stents to treat patients with debilitating claudication associated with femoropopliteal (FP) atherosclerotic lesions...
- Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trialStephan H Duda
Center for Diagnostic Radiology and Minimally Invasive Therapy, The Jewish Hospital Berlin, Heinz Galinski Strasse 1, 13347 Berlin, Germany
J Endovasc Ther 13:701-10. 2006..To review clinical outcomes of patients with chronic limb ischemia and TASC type C lesions treated with sirolimus-eluting versus bare SMART nitinol self-expanding stents...
- Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registryJohn Laird
Washington Hospital Center, Division of Cardiology, Indianapolis, IN, USA
J Vasc Interv Radiol 16:1067-73. 2005..This article presents the results of a prospective, multicenter trial that evaluated the efficacy of cryoplasty for femoropopliteal disease...
- Protected carotid stenting in high-risk patients with severe carotid artery stenosisRobert D Safian
Cardiac and Vascular Intervention, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
J Am Coll Cardiol 47:2384-9. 2006..The purpose of this study was to determine the safety of carotid artery stenting with a unique distal embolic protection system in high-risk patients with severe carotid stenosis...
- Diagnosis of peripheral arterial disease: utility of the vascular laboratoryMichael R Jaff
Vascular Diagnostic Laboratory, Heart and Vascular Institute, Morristown, New Jersey, USA
Clin Cornerstone 4:16-25. 2002..This article describes the basic noninvasive diagnostic tests, criteria for diagnosis, advantages and disadvantages of each diagnostic modality, and a strategy for PAD therapy...
- The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methodsTimothy P Murphy
Rhode Island Hospital Vascular Disease Research Center and Brown Medical School Department of Diagnostic Imaging, Providence, RI 02903, USA
J Vasc Surg 47:1356-63. 2008....
- Protected carotid-artery stenting versus endarterectomy in high-risk patientsJay S Yadav
Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
N Engl J Med 351:1493-501. 2004..Stenting with the use of an emboli-protection device is a less invasive revascularization strategy than endarterectomy in carotid-artery disease...
- Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trialPetr Svoboda
Intensive Care, Traumatological Hospital, Masaryk University of Brno, Czech Republic
Crit Care Med 32:1990-6. 2004..Less is known about the success of intracatheter thrombolysis in the broader range of CVAD malfunction encountered in clinical practice, especially in those devices that are totally occluded...
- Vascular medicine in 2004: major steps toward national prominenceMichael R Jaff
Society for Vascular Medicine and Biology, Annual Scientific Sessions, Anaheim, CA, USA
Vasc Med 9:135-7. 2004
- Medical treatment of peripheral arterial disease: a comprehensive reviewAthanasios Stoyioglou
Department of Cardiology, Lenox Hill Hospital, New York, New York, USA
J Vasc Interv Radiol 15:1197-207. 2004..This article will review the clinical data supporting aggressive medical interventions for patients with PAD...
- Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventioKenneth Rosenfield
J Am Coll Cardiol 45:165-74. 2005
- The top 12 advances in vascular medicineJeffrey W Olin
Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
J Endovasc Ther 11:II21-31. 2004....
- Where have we been? Where are we going?Michael R Jaff
Society for Vascular Medicine and Biology, Chicago, Illinois, USA
Vasc Med 10:231-3. 2005
- Surveillance imaging for carotid in-stent restenosisCorey K Goldman
Division of Vascular Medicine, Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
Catheter Cardiovasc Interv 67:302-8. 2006..We present three cases to illustrate the strengths and weaknesses of noninvasive imaging techniques for surveillance of carotid stents, ultimately validated with invasive contrast angiography...
- Re: The American "board" of vascular medicine: questions and concernsMichael R Jaff
J Vasc Interv Radiol 17:916-7; author reply 918. 2006
- Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on CardiChristopher J White
Circulation 114:1892-5. 2006..This multispecialty consensus document describes the rationale for patient selection for screening renal angiography at the time of cardiac catheterization...
- Noninvasive diagnostic strategies for peripheral arterial diseaseSusan M Begelman
Department of Cardiovascular Medicine, Cleveland Clinic, OH 44195, USA
Cleve Clin J Med 73:S22-9. 2006..Conventional angiography, the "gold standard" study for PAD diagnosis, is now usually pursued only once an intervention is planned...
- Carotid stent restenosis--a problem in search of a cure?Michael R Jaff
Catheter Cardiovasc Interv 69:683-4. 2007
- Factors affecting long-term survival following renal artery stentingMark C Bates
Vascular Center of Excellence, Charleston Area Medical Center, Charleston, West Virginia, USA
Catheter Cardiovasc Interv 69:1037-43. 2007..This study defines clinical variables at the time of renal artery stenting that may be predictors of long-term all-cause mortality...
- The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implicationsChristopher J White
Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
Catheter Cardiovasc Interv 71:721-5. 2008..Finally, the CARE Registry satisfies the Center for Medicare and Medicaid Services (CMS) data reporting criteria for reimbursement...
- Renal artery stenosis: searching for the algorithms for diagnosis and treatmentZoltan G Turi
J Am Coll Cardiol 41:1312-5. 2003